| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Maia Biotechnology, Inc. (MAIA) has 9 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. MAIA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.52M | $2.16M | - | |
| CEO | 976.1K | $1.39M | - | |
| Other | 60.0K | $85.2K | - | |
| Other | 46.5K | $66.0K | - | |
| Dir | 29.8K | $42.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2025 | Guerrero Ramiro | Director | Buy | 73,333 | $1.50 | $109,999.50 | +15.9% | -1.7% | +33.7% | |
| Feb 24, 2025 | Smith Stan | Director | Buy | 50,000 | $1.50 | $75,000.00 | +4.4% | -1.7% | +33.7% | |
| Dec 13, 2024 | Guerrero Ramiro | Director | Buy | 53,418 | $1.87 | $99,998.50 | +11.6% | -21.0% | -32.0% | |
| Dec 13, 2024 | Smith Stan | Director | Buy | 25,000 | $1.87 | $46,800.00 | +2.3% | -21.0% | -32.0% | |
| Nov 1, 2024 | Guerrero Ramiro | Director | Buy | 88,534 | $2.51 | $222,220.34 | +27.7% | -32.4% | -54.9% | |
| Nov 1, 2024 | Smith Stan | Director | Buy | 100,000 | $2.51 | $251,000.00 | +11.7% | -32.4% | -54.9% | |
| Nov 1, 2024 | Chaouki Steven M59 | Director | Buy | 22,133 | $2.51 | $55,553.83 | +24.9% | -32.4% | -54.9% | |
| Nov 1, 2024 | Luput Cristian | Director | Buy | 22,133 | $2.51 | $55,553.83 | +6.0% | -32.4% | -54.9% | |
| Apr 25, 2024 | Louie Ngar Yee52 | Director | Buy | 19,665 | $2.03 | $39,919.95 | +1.7% | +31.7% | -25.4% | |
| Apr 25, 2024 | Smith Stan | Director | Buy | 147,492 | $2.03 | $299,408.76 | +17.2% | +31.7% | -25.4% |